Help Your Patients Get Started on VUMERITY

2 routine steps to start and continue1

  • Complete blood count (CBC) with lymphocyte count
  • Liver tests (serum aminotransferase, alkaline
    phosphatase, and total bilirubin)
  • CBC with lymphocyte count at 6 months, every 6 to 12
    months thereafter, and as clinically indicated
  • Repeat liver tests as clinically indicated

Consider interruption of treatment in patients with
lymphocyte counts <0.5 x 109/L persisting for >6 months

There is NO requirement in the VUMERITY Prescribing Information for the following tests prior to use:

  • There are no adequate data on the developmental risk associated with the use of VUMERITY in pregnant women
  • Instruct patients that if they are pregnant or plan to become pregnant while taking VUMERITY they should inform their healthcare provider

Supporting your patients from the start

Patient Website

At patients will find information about VUMERITY, as well as a discussion guide to help facilitate a productive patient-physician dialogue.

Patient Information Brochure

An easy-to-read review of what to expect while receiving VUMERITY. It includes information on:

  • Taking VUMERITY
  • Adverse events
  • Patient support

Request a brochure from your VUMERITY sales representative now to familiarize yourself with the content.­ is a resource to help streamline the process of starting and continuing patients on a Biogen therapy.


The myVUMERITY™ app helps patients remember to take their medication and is available for download on the App Store or Google Play.


available in the Apple App Storeget it on Google Play

Biogen Support Services are here to help your patients get started on treatment and provide additional support throughout their time on a Biogen therapy. The Biogen team can be a resource for patients when they have questions about treatment. 

Fill out a Start Form to help your patients get the support they need